awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36519986-9F9A417F-EE66-4080-AEDB-DA7E631CD6C4
Q36519986-9F9A417F-EE66-4080-AEDB-DA7E631CD6C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36519986-9F9A417F-EE66-4080-AEDB-DA7E631CD6C4
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.
P2860
Q36519986-9F9A417F-EE66-4080-AEDB-DA7E631CD6C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36519986-9F9A417F-EE66-4080-AEDB-DA7E631CD6C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
965eb163a87c17f22219cc72e4c1bf1442c280a9
P2860
B cell receptor signaling in chronic lymphocytic leukemia.